Citation Impact
Citing Papers
Prostate Cancer Induces Bone Metastasis through Wnt-Induced Bone Morphogenetic Protein-Dependent and Independent Mechanisms
2008
Autonomic Nerve Development Contributes to Prostate Cancer Progression
2013 StandoutScience
Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus177Lu-DOTA-PESIN)
2011
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Differential SPARC mRNA expression in Barrett's oesophagus
2003
BMP7 inhibits branching morphogenesis in the prostate gland and interferes with Notch signaling
2005
In Vivo Evaluation and Small-Animal PET/CT of a Prostate Cancer Mouse Model Using 64Cu Bombesin Analogs: Side-by-Side Comparison of the CB-TE2A and DOTA Chelation Systems
2007
Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone
2011
Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease
2001
Effect of localized surgical excisions in hidradenitis suppurativa
1988
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Estrogen receptors and human disease
2006 Standout
MYC on the Path to Cancer
2012 Standout
The FGF family: biology, pathophysiology and therapy
2009 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Modulation of matrix remodeling by SPARC in neoplastic progression
2009
Cancer to bone: a fatal attraction
2011 Standout
Hidradenitis suppurativa: A comprehensive review
2009 Standout
Pachydermoperiostosis: an update
2005
Estrogenic Regulation of Signaling Pathways and Homeobox Genes During Rat Prostate Development
2004
Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy
2008 Standout
Drug penetration in solid tumours
2006 Standout
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Tumor–stroma co-evolution in prostate cancer progression and metastasis
2009
Mesenchymal Factor Bone Morphogenetic Protein 4 Restricts Ductal Budding and Branching Morphogenesis in the Developing Prostate
2001
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
The prevalence of hidradenitis suppurativa and its potential precursor lesions
1996 Standout
Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states
2008
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Cathepsin K inhibitors as treatment of bone metastasis
2008
Overexpression of SPARC gene in human gastric carcinoma and its clinic–pathologic significance
2004
Controlled drug delivery vehicles for cancer treatment and their performance
2018 Standout
Plectranthus: A review of ethnobotanical uses
2005 Standout
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Extracellular matrix structure
2015 Standout
Multi-lectin Affinity Chromatography and Quantitative Proteomic Analysis Reveal Differential Glycoform Levels between Prostate Cancer and Benign Prostatic Hyperplasia Sera
2018
The differential diagnosis and comorbidity of hidradenitis suppurativa and perianal Crohn's disease
1993
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Strain‐Promoted Copper‐Free “Click” Chemistry for 18F Radiolabeling of Bombesin
2011 StandoutNobel
Deficiency of SPARC suppresses intestinal tumorigenesis in APC Min/+ mice
2007 StandoutNobel
Specific Molecular Interactions of Oversulfated Chondroitin Sulfate E with Various Heparin-binding Growth Factors
2002
LADD syndrome is caused byFGF10mutations
2006
Emerging Biological Principles of Metastasis
2017 Standout
Radiometallated peptides for molecular imaging and targeted therapy
2011
Hematopoietic Stem-Cell Transplantation
2006 Standout
TGFβ in Cancer
2008 Standout
Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment
1999
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Reflecting on 25 years with MYC
2008 Standout
Nuclear Imaging of Prostate Cancer with Gastrin-Releasing-Peptide- Receptor Targeted Radiopharmaceuticals
2008
Peptide therapeutics: current status and future directions
2014 Standout
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Microenvironmental regulation of metastasis
2008 Standout
Myc-driven murine prostate cancer shares molecular features with human prostate tumors
2003
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
Molecular imaging with nanoparticles: giant roles for dwarf actors
2008
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Modulation of prostate cancer growth in bone microenvironments
2003
VESTIBULAR FUNCTION AND MOTOR PROFICIENCY OF CHILDREN WITH IMPAIRED HEARING, OR WITH LEARNING DISABILITY AND MOTOR IMPAIRMENTS
1988
A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues
2010
Endocytosis of nanomedicines
2010 Standout
Postural strategies associated with somatosensory and vestibular loss
1990 Standout
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
2007 Standout
FGF‐8 is involved in bone metastasis of prostate cancer
2008
Critical role of reactive nitrogen species in lung ischemia–reperfusion injury
2003
Albumin-bound paclitaxel: a next-generation taxane
2006
nab-Paclitaxel mechanisms of action and delivery
2013
Peptide-based radiopharmaceuticals and cytotoxic conjugates: Potential tools against cancer
2007
Glycosaminoglycans and their proteoglycans: host‐associated molecular patterns for initiation and modulation of inflammation
2006 Standout
Part II: Beneficial Effects of the Peroxynitrite Decomposition Catalyst FP15 in Murine Models of Arthritis and Colitis
2002
Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Mediates Cell Adhesion
2004 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Protease-Activatable Fluorescence Sensor
2007
Therapeutic Nanoparticles for Drug Delivery in Cancer
2008 Standout
Benign Neoplasms of the Larynx. A 10-Year Review of 38 Patients
1983
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Phase I and Pharmacokinetics Trial of ABI-007, a Novel Nanoparticle Formulation of Paclitaxel in Patients With Advanced Nonhematologic Malignancies
2005
A Posture Control Model and Balance Test for the Prediction of Relative Postural Stability
1987
In Vivo Imaging of Matrix Metalloproteinase 12 and Matrix Metalloproteinase 13 Activities in the Mouse Model of Collagen‐Induced Arthritis
2013 StandoutNobel
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Part I: Pathogenetic Role of Peroxynitrite in the Development of Diabetes and Diabetic Vascular Complications: Studies With FP15, A Novel Potent Peroxynitrite Decomposition Catalyst
2002
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications
2015
Tandem Mass Tags: A Novel Quantification Strategy for Comparative Analysis of Complex Protein Mixtures by MS/MS
2003 Standout
Human Osteocalcin and Bone Sialoprotein Mediating Osteomimicry of Prostate Cancer Cells: Role of cAMP-Dependent Protein Kinase A Signaling Pathway
2005
18F, 64Cu, and 68Ga Labeled RGD-Bombesin Heterodimeric Peptides for PET Imaging of Breast Cancer
2009
Treatment of hidradenitis suppurativa with the carbon dioxide laser
1987
Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer
2011 Standout
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Molecular Biology of Bone Metastasis
2007
Toward a high-throughput approach to quantitative proteomic analysis: Expression-dependent protein identification by mass spectrometry
2001
Sensorimotor Integration in Human Postural Control
2002 Standout
Radiometals for Combined Imaging and Therapy
2012
Condyloma in Pregnancy Is Strongly Predictive of Juvenile-Onset Recurrent Respiratory Papillomatosis
2003 Standout
Repifermin (keratinocyte growth factor-2) reduces the severity of graft-versus-host disease while preserving a graft-versus-leukemia effect
2003
Evaluation of the Pharmacokinetic Effects of Various Linking Group Using the 111In-DOTA-X-BBN(7−14)NH2 Structural Paradigm in a Prostate Cancer Model
2008
Works of Regi Thomas being referenced
In vitro binding evaluation of 177Lu-AMBA, a novel 177Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues
2008
Placental bone morphogenetic protein(PLAB) gene expression in normal, pre-malignant and malignant human prostate: Relation to tumor development and progression
2001
Androgen-dependent gene expression of bone morphogenetic protein 7 in mouse prostate
1998
Fibroblast Growth Factor-10 Is a Mitogen for Urothelial Cells
2002
The critical role of reactive nitrogen species in lung ischemia reperfusion injury
2002
Hidradenitis suppurativa: a case presentation and review of the literature.
1985
Histiocytosis X
1970
Vestibular and visual control on posture and locomotor equilibrium
1986
Cathepsin K mRNA and Protein Expression in Prostate Cancer Progression
2003
Differential expression of osteonectin/SPARC during human prostate cancer progression.
2000
177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer.
2006